IceCure Medical Ltd. (ICCM) research
IceCure Medical Ltd.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.57
- As of
IceCure Medical Ltd. (ICCM): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-28.
As of . Source: SEC EDGAR filings for ICCM. Method and limitations.
Share the ICCM intelligence card
See the full ICCM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ICCM on one page. Preview it with sample data, then open it live with a free account.
Preview the ICCM dossierActive signals for ICCM
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 103.3%, EPS $-3.11 vs $-1.53 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 9.5% - EPS $-1.8 vs $-1.989 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 17.6% - EPS $-1.8 vs $-1.53 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 52.5% - EPS $-2.1 vs $-1.377 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 26.0% - EPS $-1.8 vs $-1.4281 estimate
FREE, NO ACCOUNT
Every signal on ICCM, as it fires
You are seeing 5 of 13 signals recorded on ICCM since 2026-05-26.
The five above landed across 2 days. The other 8 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, ICCM
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
ICCM against its peers
ICCM's operating margin of -446.7% ranks in the 35th percentile of 12 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | ICCM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.4M USD | 2.0M USD | 58 | 17 |
| Revenue YoY | 2.7% | n/a | n/a | 4 |
| Gross margin | 36.3% | 40.9% | 43 | 14 |
| Operating margin | -446.7% | -215.6% | 35 | 12 |
| Net margin | -445.6% | -182.8% | 41 | 15 |
| Return on equity | -166.4% | -143.5% | 41 | 15 |
Peers (20): AMIX, CODX, VNRX, WOK, TANAF, NVNO, INBS, PMI, IRIX, AIDX, BMRA, ALRTF, ITOC, USAQ, STME, AEMD, CTSO, SINT, PLSM, ADGM. Left out: SONX (period gap), KLYG (no annual filing), TRIB (period gap), NMTC (no annual filing), PMEDF (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ICCM: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ICCM signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ICCMand get the insider, 13F, options, and confluence read in one view.